Vertex Pharmaceuticals (VRTX) proposed sale of 1,541 shares via Fidelity
Rhea-AI Filing Summary
Vertex Pharmaceuticals reported a proposed sale notice on Form 144 listing 1,541 shares of Common Stock associated with Fidelity Brokerage Services LLC. The filing also lists restricted stock vesting events of 612 shares on 02/17/2026 and 929 shares on 02/24/2026.
Positive
- None.
Negative
- None.
Insights
Form 144 lists a proposed disposition of common stock tied to recent restricted stock vesting.
Form 144 is a notice of proposed sale under Section 16(b) mechanics; the entry shows brokerage placement through Fidelity Brokerage Services LLC and two restricted stock vesting events dated 02/17/2026 and 02/24/2026
Timing and exact sale mechanics are not detailed here; subsequent Form 4 or broker reports would show execution and proceeds. Follow-up filings will confirm whether the proposed sale was completed.